News Results - infliximab

  • FDA reviewers support Celltrion's biosimilar Remicade

    Lycos News5 Feb 2016

    (Reuters) - U.S. Food and Drug Administration staff members on Friday said clinical data from Celltrion Inc's biosimilar form of blockbuster arthritis drug Remicade indicated it is "highly similar" to the branded product in terms of safety, purity and potency.